Fig. 5From: Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetesOGTT, ITT, and serological testing results. a OGTT and ITT values at various times after administration of glucose meal or insulin. b Measurement of serum ALT and renal creatinine levels to investigate liver and kidney function. n = 3; *P < 0.05, **P < 0.01, ***P < 0.001Back to article page